A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
Rest assured, competitors Deloitte, Ernst & Young, and PricewaterhouseCoopers are likely to follow in KPMG’s tracks.
For the crypto industry, President Trump is something of an enigma. But the launch of the Trump family coins was a bit, well, embarrassing.
President Donald Trump used the first hours of his second term in office Monday to make the emergency declaration.